Metraipolis › archive › dc_ab89aa52a16d

Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer — Europe PMC PMID:41595172

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41595172
DOI
10.3390/cancers18020253
License (as archived)
solo-consultazione
Archived
2026-11-06T19:49:42.612Z
SHA-256 of the archived text
da20aebd0715294c5f8460a32f44f775be7d27fea8cc761f58ac4ff35092d4be
Stable URL of this page
https://metraipolis.com/documento/dc_ab89aa52a16d

How to cite

Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer — Europe PMC PMID:41595172 — Europe PMC (en), https://europepmc.org/article/MED/41595172 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab89aa52a16d (Metraipolis archive dc_ab89aa52a16d, sha256 da20aebd0715294c5f8460a32f44f775be7d27fea8cc761f58ac4ff35092d4be)
BibTeX
@misc{dcab89aa52a16d,
  title = {Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer — Europe PMC PMID:41595172},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41595172},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab89aa52a16d; sha256 da20aebd0715294c5f8460a32f44f775be7d27fea8cc761f58ac4ff35092d4be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595172. Agents can read the archived copy with the MCP tool read_document.